Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Ovid Therapeutics Inc’s current trading price is -57.93% away from its 52-week high, while its distance from the 52-week low is 155.05%. The stock’s price range over this period has fluctuated between $0.24 and $1.47. The company, operating within the financial sector, had a trading volume of approximately 1.07 million for the day, which was noticeably lower than the average daily share volume of 1.49 million over the last 3 months.
The stock price for Ovid Therapeutics Inc (OVID) currently stands at $0.62. The stock experienced a substantial increase in the last session, hitting $4.0 after starting at $0.62. The stock’s lowest price was $1.5 before closing at $0.69.
In terms of market performance, Ovid Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $1.47 on 11/11/24, and the lowest value was recorded at $0.24 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Ovid Therapeutics Inc (OVID) has experienced a quarterly rise of 83.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 43.98M and boasts a workforce of 23 employees.
Ovid Therapeutics Inc: What Analysts Are Saying
As of right now, 5 analysts are rating Ovid Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3619, with a change in price of +0.1252. Similarly, Ovid Therapeutics Inc recorded 1,073,163 in trading volume during the last 100 days, posting a change of +25.38%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for OVID stands at 0.24. Similarly, the long-term debt-to-equity ratio is also 0.22.
OVID Stock Stochastic Average
Today’s raw stochastic average for Ovid Therapeutics Inc over the last 50 days is 75.04%.This indicates a increase from the raw stochastic average of the past 20 days, which was 73.31%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 85.35% and 91.61%, respectively.
OVID Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -41.10%. However, over the past six months, we’ve seen a stronger performance of -12.86%. The price of OVID fallen by 96.66% over the last 30 days. And in the last five days, it has surged by 12.45%.
